Verquvo (vericiguat)

£205.95£461.29

Verquvo (vericiguat) is a medication to reduce the risk of cardiovascular death and heart failure (HF) hospitalization following a hospitalization for heart failure or need for outpatient IV diuretics, in adults with symptomatic chronic HF and ejection fraction less than 45%

DISEASE INDICATIONS

Risk of cardiovascular events

MANUFACTURER

Merck

USAGE

Oral

MEDICINE APPROVED BY

  • European Medical Agency (EMA)

  • Food and Drug Administration (FDA)

  • Pharmaceuticals and Medical Devices Agency (PMDA)

This content has been reviewed by a Medical Doctor.
VERQUVO (VERICIGUAT) Package Tablets

28 tablets x 2.5 mg, 28 tablets x 5 mg, 98 tablets x 5 mg, 98 tablets x 10 mg

Reviews

There are no reviews yet.

Be the first to review “Verquvo (vericiguat)”

Your email address will not be published. Required fields are marked *

Shopping Cart